Panasonic Healthcare buys Bayer unit for €1b

Deal for Bayer Diabetes Care is a rare example of a large overseas acquisition by a Japanese company/foreign private equity group partnership.

Panasonic Healthcare buys Bayer unit for €1b

KKR-backed Panasonic Healthcare agreed on Wednesday to buy Bayer Diabetes Care for 1 billion $1.1 billion in a rare example of a foreign private equity group and a Japanese company jointly making a large overseas acquisition.

The deal illustrates the global ambitions of Japanese companies, which are increasingly accessing cheap domestic financing to snap up overseas assets.

Bayer Diabetes Care, a unit of German pharmaceutical giant Bayer, provides blood glucose monitoring...

FinanceAsia has updated its subscription model. Registered readers now have the opportunity to read five articles from our award-winning website for free. Please subscribe for unlimited access.

Click for more on: kkr | panasonic healthcare | private equity | japan

Print Edition

FinanceAsia Print Edition